COCRYSTAL PHARMA NEW O.N. (F:8CC) — Market Cap & Net Worth
Market Cap & Net Worth: COCRYSTAL PHARMA NEW O.N. (8CC)
COCRYSTAL PHARMA NEW O.N. (F:8CC) has a market capitalization of $15.55 Million (€13.30 Million) as of September 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25979 globally and #2229 in its home market, demonstrating a -6.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COCRYSTAL PHARMA NEW O.N.'s stock price €0.97 by its total outstanding shares 13785759 (13.79 Million). Also see COCRYSTAL PHARMA NEW O.N. balance sheet assets for a full breakdown of the balance sheet.
COCRYSTAL PHARMA NEW O.N. Market Cap History: 2020 to 2026
COCRYSTAL PHARMA NEW O.N.'s market capitalization history from 2020 to 2026. Data shows change from $220.48 Million to $15.55 Million (-30.76% CAGR). Also see how efficiently does COCRYSTAL PHARMA NEW O.N. generate cash for how efficiently the company converts equity into cash flow.
COCRYSTAL PHARMA NEW O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COCRYSTAL PHARMA NEW O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest COCRYSTAL PHARMA NEW O.N. stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8CC by Market Capitalization
Companies near COCRYSTAL PHARMA NEW O.N. in the global market cap rankings as of September 19, 2026. Review 8CC intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to COCRYSTAL PHARMA NEW O.N. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $128.84 Billion | $508.34 |
| #340 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.38 Billion | $784.85 |
| #459 | CSL Ltd | AU:CSL | $60.28 Billion | AU$175.59 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $154.04 |
COCRYSTAL PHARMA NEW O.N. Historical Marketcap From 2020 to 2026
Between 2020 and today, COCRYSTAL PHARMA NEW O.N.'s market cap moved from $220.48 Million to $ 15.55 Million, with a yearly change of -30.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €15.55 Million | +19.88% |
| 2025 | €12.97 Million | -72.24% |
| 2024 | €46.74 Million | +87.10% |
| 2023 | €24.98 Million | -9.88% |
| 2022 | €27.72 Million | -74.40% |
| 2021 | €108.31 Million | -50.88% |
| 2020 | €220.48 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of COCRYSTAL PHARMA NEW O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.55 Million USD |
| MoneyControl | $15.55 Million USD |
| MarketWatch | $15.55 Million USD |
| marketcap.company | $15.55 Million USD |
| Reuters | $15.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COCRYSTAL PHARMA NEW O.N.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hep… Read more